Rushit Lodaya | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Dr. Rushit Lodaya | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Director at GSK, United States

Rushit N. Lodaya is an accomplished leader in vaccine formulation and drug product R&D, with over a decade of expertise in developing innovative delivery platforms for nucleic acids, adjuvants, and protein antigens. He specializes in lipid nanoparticle (LNP) formulations for RNA delivery, optimizing thermostable formulations, and advancing alternative drying technologies. His contributions include multiple patents, impactful publications, and leadership roles in cross-functional collaborations, including partnerships with organizations like the NIH. A strong advocate for innovation, Rushit has significantly influenced the fields of mRNA vaccines and adjuvant development through his research and mentorship. He emphasizes a “patent-first” strategy while promoting knowledge sharing through guest editing and academic collaborations. Dedicated to sustainability and translational research, he integrates cutting-edge science with practical applications. Rushit’s leadership, scientific contributions, and commitment to fostering talent make him a standout researcher advancing the frontiers of biopharmaceuticals and vaccine technology.

Professional Profile

Education

Rushit N. Lodaya has a strong academic foundation that underpins his expertise in pharmaceutical and vaccine research. He earned his Ph.D. from Northeastern University, Boston, as a GSK Fellow, where his research focused on developing and characterizing novel self-emulsifying adjuvant systems containing α-tocopherol. Under the guidance of Dr. Mansoor M. Amiji and Dr. Derek T. O’Hagan, he conducted innovative studies to enhance immune responses in vaccine formulations, including in vivo evaluations of adjuvants and lyophilization processes for single-vial vaccines. Prior to this, he pursued undergraduate research at Mumbai University, where he formulated and evaluated sustained-release drug delivery systems. His educational journey is marked by a blend of rigorous academic research and practical applications, equipping him with a robust skill set in formulation sciences, drug delivery, and vaccine development. This educational background laid the groundwork for his impactful career in advancing cutting-edge pharmaceutical and biopharmaceutical technologies.

Professional Experience

Rushit N. Lodaya has over a decade of professional experience in pharmaceutical and biopharmaceutical research, specializing in vaccine formulation, drug delivery systems, and lipid nanoparticle (LNP) technologies. Currently serving as Associate Director of RNA Delivery Sciences at GSK Vaccines, he leads strategies to advance mRNA delivery platforms and novel characterization tools. Previously, as an Expert Scientist at GSK, he spearheaded initiatives to optimize mRNA-LNP formulations, improve vaccine adjuvant processes, and establish external collaborations for drug product innovation. His earlier roles include significant contributions to Phase III clinical development, process transfer for GMP manufacturing, and formulation of protein antigens. At Cubist Pharmaceuticals, he worked on early-stage formulations for novel antibiotics and post-operative pain management. Rushit’s experience also encompasses academic roles, supervising Ph.D. students and guest editing for journals. His dynamic career blends technical expertise, innovative research, and leadership, driving advancements in vaccine and therapeutic development to address critical global health needs.

Research Interests

Rushit N. Lodaya’s research interests lie at the intersection of vaccine formulation science, advanced drug delivery systems, and pharmaceutical innovation. He is particularly focused on developing lipid nanoparticle (LNP) platforms for RNA delivery, optimizing their composition, stability, and scalability for clinical applications. His work extends to creating novel adjuvants and understanding their mechanisms to enhance immune responses. Rushit is also deeply invested in exploring alternative drying technologies, such as lyophilization, to achieve thermostable formulations, crucial for vaccines’ global accessibility and distribution. He is enthusiastic about tackling challenges in intracellular delivery, improving endosomal escape, and enabling co-delivery systems for therapeutic and prophylactic applications. Committed to translational research, Rushit seeks to bridge the gap between preclinical discoveries and real-world implementation, addressing pressing public health needs. His passion for innovation and sustainability aligns with his goal of advancing next-generation biopharmaceuticals and vaccines that are efficient, stable, and globally impactful.

Awards and Honors

Rushit N. Lodaya has been recognized for his outstanding contributions to vaccine research and pharmaceutical sciences through various awards and honors. As a recipient of the prestigious GSK Fellowship during his Ph.D. at Northeastern University, he demonstrated exceptional research capabilities in adjuvant systems and vaccine delivery. His innovative work has earned him multiple patents, including breakthroughs in lipid nanoparticle formulations and freeze-dried RNA vaccines, highlighting his commitment to advancing cutting-edge technologies. Rushit has also been invited to serve as a guest editor for a special issue of MDPI Pharmaceutics, focusing on next-generation vaccine adjuvants, reflecting his thought leadership in the field. His role as a mentor and collaborator has further solidified his reputation, as he supervises Ph.D. students and contributes to the scientific community through impactful publications and book chapters. These accolades underscore his dedication to innovation, collaboration, and advancing pharmaceutical sciences to address global health challenges.

Conclusion

Rushit N. Lodaya is a highly suitable candidate for the Best Researcher Award. His exceptional contributions to vaccine formulation, particularly in mRNA and LNP technologies, and his leadership in advancing innovative drug product solutions make him a strong contender. While he can expand his translational and collaborative impact, his sustained excellence, significant patents, publications, and mentorship strongly align with the award’s goals. Recognizing his efforts would celebrate and encourage further advancements in the critical field of vaccine R&D.

Publications top noted

  • The continued advance of vaccine adjuvants–‘we can work it out’
    • Authors: DT O’Hagan, RN Lodaya, G Lofano
    • Year: 2020
    • Citations: 117
  • “World in motion”–emulsion adjuvants rising to meet the pandemic challenges
    • Authors: DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano
    • Year: 2021
    • Citations: 73
  • Formulation design, optimization and in vivo evaluations of an α-tocopherol-containing self-emulsified adjuvant system using inactivated influenza vaccine
    • Authors: RN Lodaya, AP Kanitkar, K Friedrich, D Henson, R Yamagata, S Nuti, …
    • Year: 2019
    • Citations: 26
  • Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant
    • Authors: Y Wen, HV Trinh, CE Linton, C Tani, N Norais, DA Martinez-Guzman, …
    • Year: 2018
    • Citations: 17
  • Stable nanoemulsions for the delivery of small molecule immune potentiators
    • Authors: RN Lodaya, LA Brito, TYH Wu, AT Miller, GR Otten, M Singh, DT O’Hagan
    • Year: 2018
    • Citations: 14
  • Overview of vaccine adjuvants
    • Authors: RN Lodaya, S Gregory, MM Amiji, DT O’Hagan
    • Year: 2022
    • Citations: 7
  • Practical aspects of vaccine development
    • Authors: P Kolhe, S Ohtake
    • Year: 2021
    • Citations: 5
  • A Self-Emulsified Adjuvant System Containing the Immune Potentiator Alpha Tocopherol Induces Higher Neutralizing Antibody Responses than a Squalene-Only Emulsion When Evaluated
    • Authors: RN Lodaya, AP Kanitkar, A Ashraf, D Bamba, MM Amiji, DT O’Hagan
    • Year: 2023
    • Citations: 3
  • Lyophilized vaccine development
    • Authors: NM Payton, RN Lodaya, AM Padilla
    • Year: 2022
    • Citations: 3
  • Nanoscale Vaccines for Influenza
    • Authors: S Bhangde, RN Lodaya, MM Amiji
    • Year: 2023
    • Citations: 1
  • Microfluidic-Chip-Based Formulation and In Vivo Evaluations of Squalene Oil Emulsion Adjuvants for Subunit Vaccines
    • Authors: S Bhangde, S Fresnay-Murray, T Garretson, A Ashraf, DT O’Hagan, …
    • Year: 2024
    • Citations: Not yet available
  • Freeze-drying of lipid nanoparticles (lnps) encapsulating rna and formulations thereof
    • Authors: R Lodaya, P Pohlhaus, E Zecca, J Zhang, A Padilla, E Bourlès, J Enert
    • Year: 2024
    • Citations: Not yet available
  • “World in motion”-emulsion adjuvants rising to meet the pandemic challenges (Vol 6, 158, 2021)
    • Authors: DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano
    • Year: 2023
    • Citations: Not yet available
  • Author Correction: “World in motion”–emulsion adjuvants rising to meet the pandemic challenges
    • Authors: DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano
    • Year: 2023
    • Citations: Not yet available
  • Review 2: “A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability”
    • Authors: HM Niknam, NS Savar
    • Year: 2022
    • Citations: Not yet available

Lakshmanan Govindan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Dr.  Lakshmanan Govindan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Saveetha Medical College and Hospital, India

Dr. Sheryene Tejeda, PhD, is an accomplished medical scientist with over 15 years of experience in clinical and scientific environments. Based in Palm Beach Gardens, Florida, she has played key roles in advancing medical research and developing innovative therapeutic protocols. Her expertise spans diverse fields such as oncology, neurology, and behavioral health. Dr. Tejeda has been instrumental in her positions, including Lead Medical Scientist at Medicinal Technologies, Contract Co-occurring Consultant, and Clinical Research Associate, where she contributed to cutting-edge research and patient care strategies. Her career is marked by a deep commitment to integrating science and holistic health approaches.

Professional Profile

Education

Dr. Tejeda’s academic background is as impressive as her professional career. She earned her PhD in Biomedical Science from Einstein Medical School, laying a strong foundation for her research in complex medical conditions. Additionally, she holds two Master’s degrees—one in Forensic Science and another in Health Science. These advanced studies equipped her with a multidisciplinary approach to healthcare, combining rigorous scientific methodology with a focus on human health outcomes. Dr. Tejeda also earned a Bachelor’s degree in Communications and Psychology, highlighting her interest in understanding human behavior alongside her scientific expertise.

Professional Experience

Dr. Tejeda’s extensive professional experience includes leadership roles in both clinical research and therapeutic development. As Lead Medical Scientist at Medicinal Technologies, she spearheaded research initiatives aimed at improving patient care through innovative medicinal approaches. Her role as a Contract Co-occurring Consultant involved working with individuals facing both mental health and substance use challenges, underscoring her commitment to integrative healthcare. In addition to her clinical work, Dr. Tejeda served as a Clinical Research Associate, contributing to various oncology and neurology trials. Her work across these roles highlights her versatility and leadership in advancing medical science.

Research Interests

Dr. Tejeda’s research interests are diverse and deeply rooted in her passion for integrative therapies and patient-centered care. She is particularly focused on oncology, where she investigates novel therapeutic approaches to cancer treatment. Additionally, she has a keen interest in neurology, exploring the intersections of neuroscience, behavior, and mental health. Her research also extends into behavioral health, where she looks at co-occurring disorders and the development of more effective treatment protocols. Dr. Tejeda’s interdisciplinary approach allows her to contribute meaningful insights into complex health challenges, with a focus on improving both treatment outcomes and patient quality of life.

Awards and Honors

Throughout her career, Dr. Tejeda has received numerous awards and recognitions for her contributions to medical research and healthcare. Her innovative work in oncology and neurology has been particularly lauded, earning her accolades within the scientific community. Additionally, her efforts in integrative and patient-focused care have resulted in recognition for her commitment to improving therapeutic practices. While specific awards have marked her journey, it is her ongoing dedication to advancing medical science and holistic health that continues to distinguish her as a leader in her field. Her work remains an inspiration to her colleagues and the broader medical community.

Conclusion

Dr. Lakshmanan’s extensive experience in medicinal plant research, advanced laboratory techniques, and interdisciplinary publications make him a deserving candidate for the Best Researcher Award. His innovative work in cancer and diabetes treatments has potential for wide-reaching applications in healthcare. Strengthening his grant acquisition and international research collaborations would further solidify his standing as a leading researcher in his field.

Publication top noted

  • Kamakshi, S., Anantha Lakshmi, P., Shenbhagaraman, R., Lakshmanan, G., Selvakumari, J.
    Antibacterial and photo dye degradative ability of copper oxide nanoparticles from Pleurotus cystidiosus
    Nano Express, 2024, 5(2), 025029
    📝 0 Citations
  • Muthu, S., Gopal, V., AL-Younis, Z.K., Giuffrè, A.M., Govindan, L.
    Extraction, purification, and investigation of the antibacterial potential of lysozyme isolated from the latex of Calotropis procera
    European Food Research and Technology, 2024, 250(5), pp. 1401–1416
    📝 0 Citations
  • Lakshmanan, G., Altemimi, A.B., Sivaraj, C., Najm, M.A.A., Gamal Abedelmaksoud, T.
    Imperatorin from the aerial parts of Cleome viscosa L.: a characterization study and evaluation of the antibacterial activity
    Natural Product Research, 2024, 38(5), pp. 848–855
    📝 0 Citations
  • Maria Francis, Y., Karunakaran, B., Ashfaq, F., Govindan, L., Ponnusamy Kasirajan, S.
    Mercuric Chloride Induced Nephrotoxicity: Ameliorative Effect of Carica papaya Leaves Confirmed by Histopathology, Immunohistochemistry, and Gene Expression Studies
    ACS Omega, 2023, 8(24), pp. 21696–21708
    📝 3 Citations
  • Sivalingam, A.M., Altemimi, A.B., Abdul-Abbas, S.J., Cacciola, F., Devaraj, N.
    Anti-Hyperglycaemic properties of an ethanolic extract from Costus spicatus (jacq) on Streptozotocin-induced diabetic male albino Wistar rats
    Moroccan Journal of Chemistry, 2023, 11(4), pp. 917–931
    📝 0 Citations
  • Rengarajan, S., Thangavel, N., Sivalingam, A.M., Selvakumari, J., Pandian, A.
    Green synthesis and characterization of silver nanoparticles with different solvent extracts of Sesbania grandiflora (L.) Poiret and assessment of their antibacterial and antioxidant potentials
    Biomass Conversion and Biorefinery, 2023
    📝 5 Citations
  • Lakshmanan, G., Selvam, R., Altemimi, A.B., Jayalakshmi, G., Pratap-Singh, A.
    Phytochemical screening of ethanolic extracts of Cuminum cyminum L. seeds along with the evaluation of antidiabetic properties by molecular docking approach
    Natural Product Research, 2023, 37(4), pp. 681–686
    📝 3 Citations
  • Vijayaraj, R., Altaff, K., Lakshmanan, G., Palanisamy, M., Alothaim, A.S.
    Inhibitory Activity of Chitin, (2-Acetamido-2-Deoxy-Hexopyranose) against Penicillin-Binding Proteins of Staphylococcus aureus
    Coatings, 2022, 12(12), 1854
    📝 4 Citations
  • Radhakrishnan, M., Palayam, M., Altemimi, A.B., Cacciola, F., Govindan, L.
    Leucine-Rich, Potent Anti-Bacterial Protein against Vibrio cholerae, Staphylococcus aureus from Solanum trilobatum Leaves
    Molecules, 2022, 27(4), 1167
    📝 2 Citations
  • Rama, P., Baldelli, A., Vignesh, A., Murugesan, K., Pratap-Singh, A.
    Antimicrobial, antioxidant, and angiogenic bioactive silver nanoparticles produced using Murraya paniculata (L.) jack leaves
    Nanomaterials and Nanotechnology, 2022
    📝 14 Citations

Sheryene Tejeda | Pharmacology | Women Researcher Award

Posted on by ScienceFather

Dr. Sheryene Tejeda | Pharmacology| Women Researcher Award

Scientist and doctor at Medicinal Technologies, United States

Dr. S. Tejeda is an accomplished medical scientist with over 15 years of experience in managing clinical and scientific services across various healthcare sectors. With a PhD in Biomedical Science from Einstein Medical School, Dr. Tejeda has dedicated her career to researching integrative therapies and providing innovative treatment protocols. Her expertise lies in developing both modern and alternative medicine approaches aimed at treating a wide range of conditions and diseases, helping countless individuals achieve better health outcomes. Dr. Tejeda’s academic background is complemented by her advanced degrees in Criminal Justice/Forensic Science, Health Science, and Psychology.

Professional Profile

Education✍️

Dr. S. Tejeda holds an MD/PhD in Biomedical Science from Einstein Medical School, making them a highly accomplished medical scientist with both clinical and research expertise. In addition to this, they possess three Master’s degrees, including a Master of Science (MFS) in Criminal Justice/Forensic Science from Ashford University, a Master of Health Science (MHS) from St. Francis University, and a Master of Arts (MA) in Psychology, which has provided a deep understanding of human behavior and mental health. Dr. Tejeda is the creator of “The Tejeda Equation” ((∑(σX GnRH ⇒ JEG3f )+ (σα ^βER ) ∴ NR3A1 ≥ 300-437pg/ml e (τ +30dy)∆ δEEC)), which is named after them and revolutionized the understanding of how Endometriosis develops. Prior to this discovery, Endometriosis was not well understood, nor classified as a disease, until Dr. Tejeda’s groundbreaking findings. Beyond their educational accomplishments, Dr. Tejeda founded a counseling firm in 2011, where they served as a co-occurring forensic therapist, and established The Tejeda Foundation, which provides essential services to impoverished individuals. Their educational background and extensive professional contributions highlight their commitment to advancing both scientific understanding and community welfare.

Professional Experience♻️

Dr. Tejeda has held multiple leadership roles throughout her career. Since 2018, she has served as the Lead Medical Scientist at Medicinal Technologies, where she founded a unique venture providing affordable alternative medicine protocols. She has conducted extensive research and development to create new treatment methods and find alternative cures for various common ailments. Prior to this, she worked as a Contract Co-occurring Consultant and Psychometrist, assisting with the assessment and treatment of dually diagnosed patients. She also held roles as a Clinical Research Associate (CRA) in oncology, hematology, and neurology at major institutions such as GlaxoSmithKline and Regional Medical Center, where she led field monitoring visits and mentored junior CRAs. Her experience includes a strong background in psychiatric care, having worked as a Clinical Liaison and Mobile Therapist at Foundations Behavioral Health and a Co-occurring Program Specialist at Terros, where she facilitated psycho-educational groups and developed community outreach programs. Dr. Tejeda’s early career in cardiology and oncology trials at Brownsville General Hospital gave her a solid foundation in clinical assessments, medication evaluation, and research coordination.

Research Interest🧬

Dr. S. Tejeda’s research interests span across integrative medicine, clinical diagnostics, and forensic science, with a strong focus on understanding complex diseases and developing alternative therapeutic solutions. Dr. Tejeda’s pioneering work on The Tejeda Equation, which explains the mechanism of action for the development of Endometriosis, is a hallmark achievement that has advanced the understanding of the disease, which was previously not well classified. Their research also extends to exploring innovative protocols for common diseases through a combination of modern and alternative medicine. Dr. Tejeda is particularly interested in the intersection of psychology and medicine, focusing on the role of mental health in disease management. Additionally, their background in forensic science allows them to delve into criminal justice applications, particularly related to behavioral health. The overarching goal of their research is to contribute to the development of holistic, accessible healthcare solutions that improve patient outcomes.

Research Skill📈

Dr. S. Tejeda possesses advanced research skills honed over 15+ years in the medical and scientific fields. Their expertise includes designing and conducting clinical studies, where they employ rigorous methodologies to ensure data integrity and validity. Proficient in using statistical software and clinical trial management systems like Phase Forward InForm and OpenClinica, Dr. Tejeda excels in data collection, analysis, and interpretation. They have a strong background in evaluating treatment protocols, focusing on integrative therapies, and developing innovative approaches to address complex medical conditions. Additionally, their research contributions include creating the Tejeda Equation, which elucidates the mechanism of endometriosis, significantly advancing the understanding of this condition. Dr. Tejeda’s ability to synthesize findings, collaborate with interdisciplinary teams, and communicate results effectively underscores their commitment to advancing medical knowledge and improving patient outcomes. These skills are vital in navigating the challenges of clinical research and enhancing healthcare delivery.

Award and Honors🏆

Dr. S. Tejeda has received numerous awards and honors in recognition of their significant contributions to the fields of medicine, research, and community service. Notably, they were awarded the Innovative Research Award for their groundbreaking work on the Tejeda Equation, which elucidates the mechanisms underlying endometriosis. This research has transformed the understanding of the condition and has been instrumental in developing targeted treatment protocols. Additionally, Dr. Tejeda was honored with the Community Service Excellence Award for founding the Tejeda Foundation, which provides essential services and support to impoverished individuals, demonstrating a commitment to social responsibility and health equity. Their leadership in promoting integrative therapies and alternative medicine has also garnered accolades from professional organizations, recognizing their dedication to advancing healthcare solutions. Through these accomplishments, Dr. Tejeda exemplifies excellence in both scientific inquiry and community impact, making a lasting difference in the lives of many.

Co-Occurring Program Specialist🌟

  • Behavioral Health Assessment: Skilled in researching and reviewing patients’ medical and psychological histories, hospitalizations, medications, and diagnoses to evaluate current symptomology and develop personalized treatment plans.
  • Acuity & Functionality Evaluation: Proficient in assessing clients’ levels of acuity and independent functioning using the Global Assessment of Functioning (GAF), determining their mental and behavioral health needs.
  • Motivational Interviewing & ASAM Assessments: Conducted motivational interviews and utilized the American Society of Addiction Medicine (ASAM) assessment tools to identify clients’ stages of recovery, ensuring they received appropriate care.
  • Psycho-Educational & Supportive Counseling: Facilitated both group psycho-educational sessions and one-on-one counseling, addressing various mental health and behavioral challenges.
  • Innovative Therapeutic Approaches: Introduced and coordinated alternative therapies, such as on-site pet therapy, to enhance clients’ engagement and healing.
  • Community Outreach & Program Promotion: Actively promoted behavioral health programs through the design and distribution of brochures, flyers, and other materials to raise awareness within the community.
  • Forensic Therapy & Rehabilitation Coordination: Specialized in working with clients involved in the legal system by drafting letters, proposals, and documentation for probationary terms reduction and completion.

Skills🌊

  • Clinical Assessment: Skilled in evaluating patients’ health conditions, diagnosing symptoms, and recommending appropriate treatment plans.
  • Medical Diagnostics: Proficient in the use of diagnostic tools and technologies to identify and treat a variety of medical conditions.
  • Psychometrics: Expertise in psychological testing and measurement, including the development and analysis of tests that assess mental and cognitive functions.
  • Phase Forward InForm & OpenClinica: Advanced knowledge of clinical trial management systems used for data collection, management, and reporting in clinical research.
  • Windows & Microsoft Office: Proficient in operating systems and office productivity tools for efficient project management, data analysis, and documentation.
  • Data Analysis: Strong analytical skills in processing and interpreting research and clinical data to derive meaningful insights.

Certificates🎓

  • Clinical Research Certification (CRC) from the Collaborative Institutional Training Initiative (CITI), which qualifies them to lead and manage clinical research studies in compliance with rigorous ethical and scientific standards.
  • Phlebotomy Training Certification from the CPI (Certified Phlebotomy Institute), enabling them to perform blood draws and handle biological specimens in clinical settings.
  • CPR & First Aid Certification from MCAP, ensuring proficiency in emergency medical response and life-saving techniques.

Conclusion

Dr. Sheryene Tejeda is a highly qualified candidate for the Research for Women Researcher Award, with significant experience, a strong educational background, and a commitment to community health. By focusing on enhancing her visibility through publications, networking, and showcasing specific research outcomes, she could further strengthen her application. Overall, her innovative approach and dedication to integrative therapies position her well to be recognized for her contributions to research and healthcare.

Publications top noted✍️

  • “Reversal Processes by Dynamic Therapies: Pathophysiology, Biomarkers and Integrative Applications for Endometriosis: Case Report”✍️ Author: SN Tejeda📅 Year: 2023

    📊 Cited by: 9

  • “Decoding the Role of Genetic Biomarkers in Neurodegenerative Diseases-Dysregulations of RNA Binding Protein Aggregations and Molecular Pathophysiologies”✍️ Author: DS Tejeda📅 Year: 2023

    📊 Cited by: 6

  • “Presigen IV: A Novel Biocellular Approach to Intraocular Pressure Regulation and Glaucoma Management”✍️ Author: DS Tejeda📅 Year: 2024

    📊 Cited by: 4